These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 6060632)

  • 41. [Treatment of ischemic brain lesions].
    Eichhorn O
    Med Welt; 1969 Oct; 42():2314-8. PubMed ID: 4982284
    [No Abstract]   [Full Text] [Related]  

  • 42. [Agents to improve cerebrovascular circulation and cerebral metabolism--calcium antagonists].
    Kyoi K; Utsumi S
    Nihon Rinsho; 1985 Feb; 43(2):368-71. PubMed ID: 3889411
    [No Abstract]   [Full Text] [Related]  

  • 43. [Pathogenesis and therapy of cerebral circulation disorders, especially of the posterior cranial fossa].
    Gottstein U
    HNO; 1969 Aug; 17(8):229-34. PubMed ID: 5405599
    [No Abstract]   [Full Text] [Related]  

  • 44. [Rational selection of vasoactive drugs for the treatment of patients with vestibular dysfunction].
    Boĭko NV
    Vestn Otorinolaringol; 1991; (5):42-7. PubMed ID: 1755185
    [No Abstract]   [Full Text] [Related]  

  • 45. [Agents to improve cerebrovascular circulation and cerebral metabolism--cinepazide].
    Fujishima M
    Nihon Rinsho; 1985 Feb; 43(2):379-82. PubMed ID: 3999408
    [No Abstract]   [Full Text] [Related]  

  • 46. [Trial of using Cavinton in cerebrovascular disorders].
    Shtok VN; Eremeeva SV
    Klin Med (Mosk); 1982 Oct; 60(10):39-42. PubMed ID: 6757560
    [No Abstract]   [Full Text] [Related]  

  • 47. Vasodilators in senile dementia.
    Br Med J; 1979 Sep; 2(6189):511-2. PubMed ID: 497664
    [No Abstract]   [Full Text] [Related]  

  • 48. [Therapy of cerebral circulation disorders in advanced age].
    Meyer HH
    Med Klin; 1966 Jan; 61(1):1-4. PubMed ID: 5985388
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of cyclandelate on cerebral cortex perfusion-rates in cerebrovascular disease.
    O'Brien MD; Veall N
    Lancet; 1966 Oct; 2(7466):729-30. PubMed ID: 4162060
    [No Abstract]   [Full Text] [Related]  

  • 50. Regional cerebral blood flow and cariovascular effects of hexobendine in stroke patients.
    McHenry LC; West JW; KEnton EJ; Oshiro T; Jaffe ME; Cooper ES; Kawamura J; Goldberg HI
    Neurology; 1972 Mar; 22(3):217-23. PubMed ID: 5062256
    [No Abstract]   [Full Text] [Related]  

  • 51. Cerebral vasospasm, 1965.
    Thomas LM; Scratch GP; Gurdjian ES
    Minn Med; 1966 Jan; 49(1):55-8. PubMed ID: 5901199
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effect of stugeron on cerebral hemodynamics in patients with disorders of the cerebral circulation].
    Iarullin KhKh; Khadzhiev D; Peniazeva GA; Levchenko NI
    Klin Med (Mosk); 1972 Jan; 50(1):62-9. PubMed ID: 5020032
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of mental manifestations of chronic cerebral circulatory insufficiency. Clinical and psychometric study].
    Lefebvre P; Crocq L; Bernard JG
    Sem Hop; 1969 Jan; 45(5):312-7. PubMed ID: 4307724
    [No Abstract]   [Full Text] [Related]  

  • 54. [Utilization of 1035 MD in cerebral ischemia disorders].
    Warot P; Petit H
    Lille Med; 1969 Feb; 14(2):78-82. PubMed ID: 5384128
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical tests, in psychiatry, of a modifier of cerebral circulation: 1035 M.D].
    Porot M; Couadau A; Petit G; Lajoinie J
    Ann Med Psychol (Paris); 1968 Mar; 1(3):442-7. PubMed ID: 5670017
    [No Abstract]   [Full Text] [Related]  

  • 56. [Treatment of patients with initial manifestations of cerebral circulation insufficiency in vasomotor dystonias].
    Kanareĭkin KF; Manvelov LS
    Klin Med (Mosk); 1992; 70(5-6):56-60. PubMed ID: 1434406
    [No Abstract]   [Full Text] [Related]  

  • 57. [Experiences on the treatment of cerebral insufficiency and peripheral circulation disorders with the test preparation EP 50-100].
    Bock KJ
    Med Welt; 1972 Feb; 23(8):273-5. PubMed ID: 5012543
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of tardokrein in vascular diseases of the nervous system].
    Wasilewski R; Rubach K; Bortnowska M
    Neurol Neurochir Pol; 1972; 6(5):855-60. PubMed ID: 4655989
    [No Abstract]   [Full Text] [Related]  

  • 59. [Cerebrovascular-dilator agents].
    Goto F
    Nihon Rinsho; 1970 Mar; 28 Suppl():718-21. PubMed ID: 5430850
    [No Abstract]   [Full Text] [Related]  

  • 60. [Process and methods of study of cerebral circulation under peripheral vasodilator in the aged].
    Roberti A
    Therapeutique; 1969 Dec; 45(10):1041-3. PubMed ID: 5394110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.